<SEC-DOCUMENT>0001214659-22-012433.txt : 20221019
<SEC-HEADER>0001214659-22-012433.hdr.sgml : 20221019
<ACCEPTANCE-DATETIME>20221018173332
ACCESSION NUMBER:		0001214659-22-012433
CONFORMED SUBMISSION TYPE:	PX14A6G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20221019
DATE AS OF CHANGE:		20221018
EFFECTIVENESS DATE:		20221019

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRINKER INTERNATIONAL, INC
		CENTRAL INDEX KEY:			0000703351
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-EATING PLACES [5812]
		IRS NUMBER:				751914582
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0629

	FILING VALUES:
		FORM TYPE:		PX14A6G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10275
		FILM NUMBER:		221316738

	BUSINESS ADDRESS:	
		STREET 1:		3000 OLYMPUS BLVD.
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75019
		BUSINESS PHONE:		9729809917

	MAIL ADDRESS:	
		STREET 1:		3000 OLYMPUS BLVD.
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRINKER INTERNATIONAL INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHILIS INC
		DATE OF NAME CHANGE:	19910528

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AS YOU SOW
		CENTRAL INDEX KEY:			0001086462
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			CA

	FILING VALUES:
		FORM TYPE:		PX14A6G

	BUSINESS ADDRESS:	
		STREET 1:		2150 KITTREDGE ST.
		STREET 2:		SUITE 450
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94704
		BUSINESS PHONE:		510-735-8155

	MAIL ADDRESS:	
		STREET 1:		2150 KITTREDGE ST.
		STREET 2:		SUITE 450
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94704
</SEC-HEADER>
<DOCUMENT>
<TYPE>PX14A6G
<SEQUENCE>1
<FILENAME>r1018221px14a6g.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD ROWSPAN="2" STYLE="white-space: nowrap; vertical-align: top; width: 10%"><IMG SRC="asyousowlogo.jpg" ALT=""><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; width: 10%"><FONT STYLE="font-size: 8pt; color: #00813D">Main Post Office, P.O. Box 751&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD STYLE="text-align: left; vertical-align: bottom; width: 80%; white-space: nowrap"><FONT STYLE="font-size: 8pt; color: #73C167"><B>www.asyousow.org</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 8pt; color: #00813D">Berkeley, CA 94704</FONT></P>
                                    <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 8pt; color: #00813D"> &nbsp;&nbsp;&nbsp;</FONT></P></TD>
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 7.5pt; color: #73C167">BUILDING A SAFE, JUST, AND SUSTAINABLE WORLD SINCE 1992</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">
Notice of Exempt Solicitation Pursuant to Rule 14a-103</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">Name of the Registrant: Brinker International (EAT)<BR>
Name of persons relying on exemption:&nbsp;As You Sow<BR>
Address of persons relying on exemption: Main Post Office, P.O. Box 751, Berkeley, CA 94704</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">Written materials are submitted pursuant to Rule 14a-6(g)(1) promulgated
under the Securities Exchange Act of 1934.&nbsp;Submission is not required of this filer under the terms of the Rule but is made voluntarily
in the interest of public disclosure and consideration of these important issues.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9pt; background-color: #B8CCE4">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Brinker International (EAT)<BR>
Vote Yes: Item #5 &ndash; Shareholder Proposal on Report on Measures Taken to End the Use of Medically Important Antibiotics</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">Annual Meeting:
November 17, 2022 </FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CONTACT: Danielle Fugere| dfugere@asyousow.org</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9pt; background-color: #B8CCE4">THE RESOLUTION</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Be it Resolved:</B> Shareholders request that Brinker International
report on measures the company is taking to end use of medically important antibiotics in its beef and pork supply chains.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Supporting Statement: </B>Shareholders recommend the disclosure
include, at board and company discretion:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Strategies and timelines for reduction or elimination of medically important antibiotic use in beef and pork supply chains.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Assessment of supplier animal welfare and sanitation standards which reduce the need for medically important antibiotics.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9pt; background-color: #B8CCE4">SUMMARY</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">Antibiotic resistance is one of the biggest threats to health and human
development. When antibiotics are overused or misused, antibiotic-resistant bacteria can spread. As antibiotics become less effective,
common infections in humans and animals become harder, and sometimes impossible, to treat.<SUP>1</SUP> This resistance to antibiotics
results in higher medical costs, longer hospital stays, and increased mortality. According to the Centers for Disease Control and Prevention
(CDC), at least 2 million Americans contract an antibiotic-resistant infection every year, and 23,000 will
die from it.<SUP>2</SUP></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP> https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>2</SUP> https://www.cdc.gov/drugresistance/about.html</P>

<P STYLE="color: #71C267; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: #71C267; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #71C267">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap; width: 10%"><IMG SRC="asyousowlogo.jpg" ALT=""><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD STYLE="white-space: nowrap; width: 90%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 9pt; color: rgb(0,129,61)"><B>2022
Proxy Memo</B></FONT></P>
                                                <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; color: #00813B"><FONT STYLE="font-size: 10pt; color: #00813D"><B></B></FONT><FONT STYLE="font-size: 10pt; font-weight: normal">Brinker International | Shareholder Proposal on Medically Important Antibiotic Use</FONT></P>
                                                <P STYLE="margin-top: 0; margin-bottom: 0"></P></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">The use of antibiotics in agriculture is a major part of this problem.
More than 70 percent of the medically important antibiotics sold in the U.S. are used in animal agriculture.<SUP>3</SUP> Most of these
antibiotics are used in cattle and swine, where heavy reliance on antibiotics is necessary due to the poor conditions in which the livestock
are kept.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">Brinker acknowledges the problem of antibiotic resistance. In 2019,
Brinker committed to eliminate medically important antibiotic use in its chicken supply chains, announcing in 2022 that 95% of chicken
served in its restaurants are now raised with no antibiotics important to human medicine.<SUP>4</SUP></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has not made a similar reduction commitment for its beef
or pork supply chains, which are where the vast majority of antibiotics in supply chains are used.<SUP>5</SUP> Instead, it supports FDA
guidance on the elimination of antibiotic use for growth promotion and feed conversion, and use of antibiotics under the supervision of
a vet. Brinker does not disclose whether it requires suppliers to comply with the guidance, and in what instances, or merely suggests
they do so. Beyond supporting FDA guidance, the company notes that, for pork and beef, it &ldquo;communicates&rdquo; its &ldquo;desire&rdquo;
for suppliers to optimize production practices and reduce the need for medically important antibiotics in food-producing animals. A mere
desire for action, however, is unlikely to lead to action.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">Without making a clear commitment and taking concrete action to achieve
it, the use of medically important antibiotics in Brinker&rsquo;s supply chain is unlikely to be successful. Brinker&rsquo;s failure to
commit to eliminating medically important antibiotics in its beef and pork supply chains demonstrates a failure to manage growing risk,
including the potential for legal liability, lack of competitiveness with peers, and inability to meet the growing consumer demand for
antibiotic-free meats. Investors seek greater disclosure related to how the company intends to respond to these risks.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9pt; background-color: #B8CCE4">DISCUSSION</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>1.</B></TD><TD><B>Brinker sources from suppliers whose business models depend on antibiotic use.</B></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">To produce animal products at low cost and at large scale, most animals
raised for food are bred on factory farms and housed in Concentrated Animal Feeding Operations (CAFOs). These facilities&rsquo; crowded,
stressful, and often unsanitary conditions are inherently disease-promoting. As factory farming has become the predominant model for raising
animals for food, more farmers have resorted to the practice of administering antibiotics to keep animals &ldquo;healthy&rdquo;
enough to bring to slaughter. Antibiotics provide a convenient, short-term fix to deal with the infection and disease associated with
poor conditions, without having to change those conditions. </P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>3</SUP> https://www.pewtrusts.org/en/research-and-analysis/fact-sheets/2016/12/antibiotics-and-animal-agriculture-a-primer#:~:text=Antibiotics%20used%20in%20animal%20agriculture%20contribute%20to%20the%20threat%20of,for%20use%20on%20the%20farm.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>4</SUP> https://brinker-production.cdn.prismic.io/brinker-qa/15ebae4b-8e1b-4e9f-ad48-4a4cc43f3107_Brinker+Sustainability+Report+2022.pdf</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>5</SUP> Only 6 percent of medically important antibiotics sold
are intended for use in chickens (compared to cattle&rsquo;s 43 percent, and swine&rsquo;s 37 percent). https://advocacy.consumerreports.org/wp-content/uploads/2018/10/ChainReaction4_Report_FINAL.pdf</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="color: #71C267; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: #71C267; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #71C267"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap; width: 10%"><IMG SRC="asyousowlogo.jpg" ALT=""><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD STYLE="white-space: nowrap; width: 90%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 9pt; color: rgb(0,129,61)"><B>2022
Proxy Memo</B></FONT></P>
                                                <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; color: #00813B"><FONT STYLE="font-size: 10pt; color: #00813D"><B></B></FONT><FONT STYLE="font-size: 10pt; font-weight: normal">Brinker International | Shareholder Proposal on Medically Important Antibiotic Use</FONT></P>
                                                <P STYLE="margin-top: 0; margin-bottom: 0"></P></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">As antibiotics are used in these facilities, antibiotic-resistant bacteria
are released into the environment. A 2015 study of feedlot air quality found drug-resistant bacteria were up to 4,000 percent more prevalent
in air samples collected downwind of Texas pork feedlots than those collected upwind.<SUP>6</SUP> A 2022 study found that the high use
of antibiotics in cattle feedlots can cause resistance in humans, as the resistant bacteria transfer to the soil and air around these
animal facilities.<SUP>7</SUP></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">By failing to commit to the elimination of medically important antibiotics
in its beef and pork supply chains or require an improvement in animal living conditions, Brinker allows the continued reliance on medically
important antibiotics.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD><B>Brinker has not committed to reducing or eliminating its use of medically important antibiotics in its beef and pork supply chains</B></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">In 2019, Brinker committed to eliminate antibiotics across its chicken
supply chains (except for treating animals actually diagnosed with illnesses).<SUP>8</SUP> The company reports that more than 95% of the
chicken served in Brinker restaurants is now raised with no antibiotics important to human medicine.<SUP>9</SUP> The company has made
no similar commitment for its pork and supply chains.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">Rather, it states that it communicates a &ldquo;desire&rdquo; that
its beef and pork suppliers reduce the need for medically important antibiotics. There is no indication that Brinker takes steps to translate
this desire into action. While Brinker supports FDA actions to eliminate antibiotic use for growth promotion and feed conversion, the
majority of antibiotics used on animal farms are not used for these purposes.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">Under FDA guidelines, the use of medically important antibiotics can
be approved by a veterinarian for non-routine prevention where there is a high risk of contraction of a particular infectious disease.
Feedlots are notorious for crowded and stressful conditions, for retaining viruses in the soil, and for feeding cows high-protein food
that contributes to liver disease..<SUP>10</SUP> Similarly, confined animal feeding operations raise huge numbers of animals in intensive
confinement; animals are confined indoors to cages, crates or crowded pens with poor air and light.<SUP>11</SUP> A recent study indicates
that although the use of medically important antibiotics dropped substantially in 2016, use has been increasing since 2017.<SUP>12</SUP>
In a 2017 FDA survey, 77.8 percent of large feedlots and 53.8 percent of small feedlots indicated that they were using medically important
antibiotics in feed.<SUP>13</SUP></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>6</SUP> Hatcher, &ldquo;Occurrence of Methicillin-Resistant Staphylococcus
aureus in Surface Waters Near Industrial Hog Operation Spray Fields,&rdquo; Science of the Total Environment 565 (December 2016): 1028-1036,
doi: 10.1016/j.scitotenv.2016.05.083.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>7</SUP> https://www.abc.net.au/news/2022-01-12/cattle-feedlots-antibiotics-resistance-/100751470</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>8</SUP> https://brinker-production.cdn.prismic.io/brinker-qa/15ebae4b-8e1b-4e9f-ad48-4a4cc43f3107_Brinker+Sustainability+Report+2022.pdf</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>9</SUP> https://brinker-production.cdn.prismic.io/brinker-qa/15ebae4b-8e1b-4e9f-ad48-4a4cc43f3107_Brinker+Sustainability+Report+2022.pdf</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>10</SUP> https://www.beefcentral.com/lotfeeding/feedlots-may-be-contributing-to-antibiotic-resistance-research-suggests/</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>11</SUP> https://repository.law.miami.edu/cgi/viewcontent.cgi?article=4683&amp;context=umlr</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>12</SUP> https://link.springer.com/article/10.1007/s40572-022-00351-x/tables/2</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>13</SUP> https://www.aphis.usda.gov/animal_health/nahms/amr/downloads/amu-feedlots_1.pdf
p. 15.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="color: #71C267; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: #71C267; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #71C267"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap; width: 10%"><IMG SRC="asyousowlogo.jpg" ALT=""><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD STYLE="white-space: nowrap; width: 90%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 9pt; color: rgb(0,129,61)"><B>2022
Proxy Memo</B></FONT></P>
                                                <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; color: #00813B"><FONT STYLE="font-size: 10pt; color: #00813D"><B></B></FONT><FONT STYLE="font-size: 10pt; font-weight: normal">Brinker International | Shareholder Proposal on Medically Important Antibiotic Use</FONT></P>
                                                <P STYLE="margin-top: 0; margin-bottom: 0"></P></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">Brinker has not adopted a commitment to reduce the use of medically
important antibiotics in its beef and pork products, and it has not described any mandatory policies to reduce its supply chain impact
on antibiotic resistance other than following FDA guidelines -- which have been ineffective in ending the use of medically important antibiotics
at the majority of feedlots. Disclosing timelines, targets, and strategies to reduce and eliminate the need for medically important antibiotics
will assist investors in better understanding Brinker&rsquo;s antibiotic-related risks and whether and how it is planning to meaningfully
reduce them.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>3.</B></TD><TD><B>Brinker is not adequately responding to changing consumer preferences.</B></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">Consumer demand for meat raised without medically important antibiotics
has steadily risen as awareness of the threat of antibiotic resistance has grown. Nearly 80 percent of consumers are concerned about antibiotic
use in meat production. When asked to cite reasons for their concerns, human health and animal welfare were the most common responses.<SUP>14</SUP>
Antibiotic-free labels are important to two-thirds of American consumers, and more than 77 percent of consumers want meat producers to
&ldquo;release independent verified data&rdquo; to show that antibiotic-free claims are valid.<SUP>15</SUP> 75% of consumers are willing
to pay more for meat raised in a manner that prevents antibiotic resistance.<SUP>16</SUP></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>4.</B></TD><TD><B>Regulatory and legal risks are increasing as antibiotic resistance threatens public health. </B></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">In 2017, the FDA released industry guidance disallowing the use of
medically important antibiotics in food animals for the purpose of growth promotion. However, federal guidelines continue to allow producers
to routinely use medically important antibiotics for disease prevention. This major loophole accounts for a significant amount of the
continued overuse of these drugs, as producers may consider animals to be at risk of disease due to poor, unsanitary conditions on farms
and feedlots. The European Union, by comparison, implemented a policy in 2022 to ban all prophylactic use of medically important antibiotics
in food animals (including for disease prevention). Following the EU&rsquo;s lead, public health advocates recommend the adoption of this
level of restriction in the U.S., and legislators have increasingly supported such a proposal.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">As antibiotic resistance spreads, many Americans will be infected with
illnesses &ndash; sometimes fatal &ndash; that will no longer respond to existing antibiotics. Restaurant chains that allow medically
important antibiotics in their meat supply chains, thereby facilitating or allowing increased risk of antibiotic-resistant superbugs,
may face liability if their consumers fall victim to antibiotic-resistant illnesses. </P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>14</SUP> https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654221/#:~:text=Of%20the%20105%20studies%20that,the%20main%20reasons%20for%20concern.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>15</SUP> https://www.forbes.com/sites/johnzogby/2021/02/11/antibiotic-free-labels-are-important-to-two-thirds-of-americans-when-buying-meat---and-data-to-back-up-claims-is-paramount-a-new-poll-shows/?sh=7e99fb7d3c2b</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>16</SUP> https://www.forbes.com/sites/johnzogby/2021/02/11/antibiotic-free-labels-are-important-to-two-thirds-of-americans-when-buying-meat---and-data-to-back-up-claims-is-paramount-a-new-poll-shows/?sh=4046e7283c2b</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap; width: 10%"><IMG SRC="asyousowlogo.jpg" ALT=""><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD STYLE="white-space: nowrap; width: 90%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 9pt; color: rgb(0,129,61)"><B>2022
Proxy Memo</B></FONT></P>
                                                <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; color: #00813B"><FONT STYLE="font-size: 10pt; color: #00813D"><B></B></FONT><FONT STYLE="font-size: 10pt; font-weight: normal">Brinker International | Shareholder Proposal on Medically Important Antibiotic Use</FONT></P>
                                                <P STYLE="margin-top: 0; margin-bottom: 0"></P></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><B>5.</B></TD><TD><B>Other major restaurant chains have demonstrated leading strategies to manage these risks. </B></TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">Brinker is behind its peers in addressing the critical issue of antibiotics
in meat. Major restaurant brands have acted to substantially reduce or end the use of medically important antibiotics in its meat supply
chains. Wendy&rsquo;s has set a goal to source 100% of its U.S. and Canadian beef, chicken, and pork from suppliers that prohibit the
routine use of medically important antibiotics by 2030.<SUP>17</SUP> McDonald&rsquo;s announced a policy to reduce the need for antibiotics
in production of its food animals, applying the policy to 85% of its global beef supply chain.<SUP>18</SUP> The Cheesecake Factory is
expanding use of &ldquo;No Antibiotics Ever&rdquo; meat to beef and pork.<SUP>19</SUP> 99% of Panera&rsquo;s pork and 100% of its chicken
is raised without antibiotics.<SUP>20</SUP></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9pt; background-color: #B8CCE4">RESPONSE TO BRINKER&rsquo;S
BOARD OF DIRECTORS&rsquo; STATEMENT IN OPPOSITION</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">In Brinker&rsquo;s opposition statement, the company states that the
requested report is unnecessary because the company&rsquo;s beef and pork suppliers are not permitted to use antibiotics important to
human medicine for purposes of growth promotion, and that antibiotics important to human medicine may only be used for the treatment,
control, and prevention of illness at the direction of a qualified veterinarian.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">This statement is misleading in failing to recognize that use of medically
important antibiotics in the treatment, control, and prevention of illness, even when under the direction of a veterinarian, can be a
source of antibiotic resistance, and therefore it poses a public health risk. This is especially true when it occurs in confined animal
feeding facilities and feedlots that allow resistant bacteria to breed, spread, and escape into the environment through the air, water,
and other sources.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">Through this proposal, shareholders seek to understand how the company
plans to end the use of medically important antibiotics in its beef and pork supply chains and along what timeframes. Conducting the requested
report would allow the company and shareholders to: better understand the sources of illness in Brinker&rsquo;s supply chain animals;
ascertain whether antibiotic use is increasing or decreasing and at what rate; and determine how best to address these problems without
the use of medically important antibiotics.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">The opposition statement maintains that Brinker periodically updates
its position on antibiotic use. Brinker&rsquo;s two sustainability reports demonstrate its commitment to eliminating antibiotic use across
its chicken supply chains. Indeed, between 2021 and 2022, the company has dramatically reduced the use of medically important antibiotics
in its chickens.<SUP>21,22</SUP> Yet, Brinker has failed to make a similar commitment to eliminating or reducing the use of medically
important antibiotics in its beef and pork supply chains. Brinker states that it communicates the desire to reduce the need for antibiotics
with its pork and beef suppliers. Yet, the company does not provide information on how it plans to align its practices with these desires.
Disclosure of timelines, targets, and strategies to reduce and eliminate the need for medically important antibiotics will assist investors
in better understanding Brinker&rsquo;s antibiotics-related risks and whether and how it is planning to address them.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">Finally, Brinker states that its position on antibiotic use is consistent
with the majority of the company&rsquo;s peers that are of a similar size and with similar resources. Yet, both Panera and the Cheesecake
Factory -- restaurant chains with similar numbers of locations as Brinker -- have made more ambitious commitments than Brinker to reduce
and eliminate the use of medically important antibiotics in their meat supply chains. Other restaurants are
similarly making greater progress. </P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>17</SUP> https://www.wendys.com/csr-what-we-value/food/responsible-sourcing/animal-welfare/antibiotic-use-policy</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>18</SUP> https://corporate.mcdonalds.com/corpmcd/en-us/our-stories/article/ourstories.beef_antibiotics.html</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>19</SUP> https://www.thecheesecakefactory.com/sites/default/files/2022-05/2021-CSR-Report-TheCheesecakeFactory.pdf</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>20</SUP> https://www.panerabread.com/en-us/food-values/food-beliefs/animal-welfare.html</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>21</SUP> https://brinker.cdn.prismic.io/brinker/c732a033-f2cf-40a1-86cf-69b62e217396_Brinker+Sustainability+Report.pdf</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>22</SUP> https://brinker-production.cdn.prismic.io/brinker-qa/15ebae4b-8e1b-4e9f-ad48-4a4cc43f3107_Brinker+Sustainability+Report+2022.pdf</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="color: #71C267; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="white-space: nowrap; width: 10%"><IMG SRC="asyousowlogo.jpg" ALT=""><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT></TD>
    <TD STYLE="white-space: nowrap; width: 90%"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 9pt; color: rgb(0,129,61)"><B>2022
Proxy Memo</B></FONT></P>
                                                <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; color: #00813B"><FONT STYLE="font-size: 10pt; color: #00813D"><B></B></FONT><FONT STYLE="font-size: 10pt; font-weight: normal">Brinker International | Shareholder Proposal on Medically Important Antibiotic Use</FONT></P>
                                                <P STYLE="margin-top: 0; margin-bottom: 0"></P></TD></TR>
</TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 13pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 9pt; background-color: #B8CCE4">CONCLUSION</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Vote &ldquo;Yes&rdquo; on this Shareholder Proposal to Report Measures
Taken to End the Use of Medically Important Antibiotics</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">In animal farming, there are alternatives to widespread antibiotic
use to control and prevent the spread of disease. Providing ample, clean space for animals are among the many improvements to living conditions
that can be made to decrease the contraction and spread of disease without use of antibiotics. These changes are not only important to
reducing antibiotic resistance but to reducing air and water pollution in animal operations. Ultimately, eliminating antibiotics in the
meat supply chain will require real changes in the way conventional farming works. At the same time, the progress Brinker has made in
reducing medically important antibiotics in its chicken over a short period of time sheds light on the potential for change.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">The increasingly conscientious consumer, concerned with public health
and animal welfare, is demanding more responsibly raised meat, and most are willing to pay more for it. Brinker has the opportunity to
respond to and profit from this consumer demand by reducing reliance on medically important antibiotics in its supply chains. Providing
information on <I>how</I> the company is moving to eliminate antibiotics in all its meat supply chains, including the disclosure of timelines,
targets, strategies, and reporting from suppliers, will help investors accurately assess material risk to our company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>--</I></B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><I>For questions, please contact Danielle Fugere, As You So</I>w, dfugere@asyousow.org</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">THE FOREGOING INFORMATION MAY BE DISSEMINATED TO SHAREHOLDERS VIA TELEPHONE,
U.S. MAIL, E-MAIL, CERTAIN WEBSITES AND CERTAIN SOCIAL MEDIA VENUES, AND SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE OR AS A SOLICITATION
OF AUTHORITY TO VOTE YOUR PROXY. THE COST OF DISSEMINATING THE FOREGOING INFORMATION TO SHAREHOLDERS IS BEING BORNE ENTIRELY BY ONE OR
MORE OF THE CO-FILERS. PROXY CARDS WILL NOT BE ACCEPTED BY ANY CO-FILER. PLEASE DO NOT SEND YOUR PROXY TO ANY CO-FILER. TO VOTE YOUR PROXY,
PLEASE FOLLOW THE INSTRUCTIONS ON YOUR PROXY CARD<I>.</I></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0">6</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>asyousowlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 asyousowlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,"XU /_; $,  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( #4
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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MG!T/:9C@IT^'\HG"MA*M+%8#&TH5J4L1@L9'!X_#5*F%Q527[V=*G2E_4O\
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M+@"6V3QYX;\.)\/M'TY1(&ADO?\ A:NE:$LEL1@Q-<7!1BK(WR3XQ^)F@/\
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MR_>PITZ_U?:E_M&%Q-%*T.=_H+\%OB7^S7\+_P!G+X=? R#6OBEJUWX7\?\
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..G.I)0A%.<Y2=Y2;?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
